What is Mahmee?
Mahmee operates as a crucial bridge within the healthcare ecosystem, connecting patients, independent health professionals, and enterprise healthcare organizations. Its platform is designed to address critical gaps in maternal and infant health services, aiming to increase access to essential care throughout the prenatal and postpartum periods. By integrating various stakeholders, Mahmee facilitates a more cohesive and effective approach to maternal and child well-being.
How much funding has Mahmee raised?
Mahmee has raised a total of $9.2M across 1 funding round:
Series A
$9.2M
Series A (2022): $9.2M with participation from Revolution and Goldman Sachs Group
Key Investors in Mahmee
Revolution
Revolution is a venture capital firm that invests in transformative technologies and iconic destinations, supporting entrepreneurs who are redefining possibilities. With over two decades of experience, they back visionary founders at every stage of the startup journey and promote innovation beyond traditional tech hubs.
Goldman Sachs Group
Goldman Sachs is a leading global investment banking, securities, and investment management firm. It provides a wide range of financial services to corporations, governments, and institutional and individual clients, including mergers and acquisitions advisory, underwriting, asset management, securities trading, and wealth management.
What's next for Mahmee?
This substantial enterprise-level funding and strategic investment signal Mahmee's strong market position and its potential for significant expansion. The capital infusion is expected to fuel further development of its integrated care delivery model, potentially enabling broader geographic reach and deeper penetration into enterprise healthcare systems. Mahmee is poised to leverage this financial backing to enhance its technological capabilities and solidify its impact on improving maternal and infant health outcomes.
See full Mahmee company page
